DelveInsight's Type 1 Diabetes pipeline report depicts a robust space with 85+ active players working to develop 100+ ...

Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

The hype about agentic AI is fading and CIOs are starting to look at practical, customer-facing use cases for the technology.